Kikule, I., Baborikina, A., Haritoncenko, I., & Karelis, G. (2022, September). Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy. Medicina.
Chicago Style (17th ed.) CitationKikule, Ilga, Alise Baborikina, Iveta Haritoncenko, and Guntis Karelis. "Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy." Medicina Sep. 2022.
MLA (9th ed.) CitationKikule, Ilga, et al. "Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy." Medicina, Sep. 2022.
Warning: These citations may not always be 100% accurate.
